Menu

RegeneRx Biopharmaceuticals, Inc. RGRX

Full chart Compare
Set alert

Price alert · RGRX

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.161 Day range 0.161
0.0002 52-week range 0.163
YTD
+266.67%
1 year
-99.32%

Revenue & Expenses

Other Income → Expenses: $183Expenses → Selling, General & Admin: $1.48MExpenses → Interest Expense: $325.65KGross Profit → Expenses: $76.76KRevenue → Gross Profit: $76.76KNet Loss → Expenses: $1.73MOther Income$183Gross Profit$76.76KNet Loss$1.73MExpenses$1.80MSelling, General & Admin$1.48MInterest Expense$325.65KRevenue$76.76K

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

RGRX annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
76.76K76.76K76.76K76.76K69.67K
76.76K76.76K76.76K76.76K69.67K
76.76K76.76K76.76K76.76K69.67K
1.48M1.41M1.37M1.34M1.39M
1.48M1.40M1.37M1.27M1.31M
-1.40M-1.33M-1.29M-1.26M-1.32M
325.65K324.88K232.63K153.41K87.28K
-1.73M-1.60M-1.52M-1.40M-1.99M
-1.73M-1.60M-1.52M-1.49M-1.99M
-1.73M-1.60M-1.52M-1.49M-1.99M
-1.73M-1.60M-1.52M-1.40M-1.99M
-0.01-0.01-0.01-0.01-0.02
-0.01-0.01-0.01-0.01-0.02
-0.01-0.01-0.01-0.01-0.02
-1.40M-1.27M-1.29M-1.25M-1.91M
-1.40M-1.27M-1.29M-1.25M-1.91M
143.55M138.59M133.36M130.97M120.72M
143.55M138.59M133.36M130.97M120.72M